Key result
HnRNP D and DL negatively regulate both their own expression and the expression of one another by alternative splicing coupled to nonsense-mediated decay.
The study identifies a novel auto- and cross-regulatory mechanism between hnRNP D and DL via alternative splicing and nonsense-mediated decay, linking hnRNP DL to hnRNP D-related diseases.
Does not alter clinical practice; leaves open translation of this mechanism to human disease.
HnRNP D, better known as AUF1, is an extensively studied protein that controls a variety of cellular pathways. Consequently, its expression has to be tightly regulated to prevent the onset of pathologies. In contrast, the cellular functions and regulation of its ubiquitously expressed paralog hnRNP DL are barely explored. Here, we present an intricate crosstalk between these two proteins. Both hnRNP D and DL are able to control their own expression by alternative splicing of cassette exons in their 3'UTRs. Exon inclusion produces mRNAs degraded by nonsense-mediated decay. Moreover, hnRNP D and DL control the expression of one another by the same mechanism. Thus, we identified two novel ways of how hnRNP D expression is controlled. The tight interconnection of expression control directly links hnRNP DL to hnRNP D-related diseases and emphasizes the importance of a systematic analysis of its cellular functions.
No takes yet. Share an insight, caveat, or question.
Kemmerer et al. (2017) studied this question. hnRNP D and DL overexpression or knockdown vs. GFP or control siRNA was evaluated on Alternative splicing and protein expression levels. HnRNP D and DL negatively regulate both their own expression and the expression of one another by alternative splicing coupled to nonsense-mediated decay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: